Back to search
FDAFDA · Food and drugs·Recall number Z-2567-2017

Segmental malefemale taper, 220mm, Sterile, Knee joint femorotibial meta/polymer constrained cemented prosthesis- Specific Knee, Hip and Nail Implants

Published June 21, 2017 · Recall initiated: February 28, 2017

Summary

FDA records medical device Class II recall Z-2567-2017, published June 21, 2017 and initiated February 28, 2017. Recalling firm: Zimmer Biomet, Inc.; Status: Terminated; Reported quantity: 9867; Lot: Item Number: 00585004622, Lot Number Expiry Date Before: March 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Zimmer Biomet Inc. initiated a field action on 02/28/2017 for sterile-packaged implants packaged in two different package configurations due to packaging design verification test failures.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Zimmer Biomet, Inc.
Distributor
Worldwide Distribution - US (nationwide) Foreign: Argentina, Australia, Belgium, Brazil, Bridgend Wales, Canada, Chile, Colombia, Dominican Republic, England, Eschbach, France, India, Italy, Japan, Jordan, Korea, Malaysia, Mexico, Netherlands, Nicaragua, Panama, Peru, Russia, Saudi Arabia, Singapore, Spain, Switzerland, Taiwan, Thailand
Lot
Item Number: 00585004622, Lot Number Expiry Date Before: March 2027
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Segmental malefemale taper, 220mm, Sterile, Knee joint femorotibial meta/polymer constrained cemented prosthesis- Specific Knee, Hip and Nail Implants recalled?

Yes. FDA published recall Z-2567-2017 on June 21, 2017. Reported hazard: Zimmer Biomet Inc. initiated a field action on 02/28/2017 for sterile-packaged implants packaged in two different package configurations due to packaging design verification test failures.

What should I do if I have this product?

Voluntary: Firm initiated · Letter